HOXD13 and hepatocellular carcinoma: We analyzed the changes in serum sPD-1 level in 9 (cases 1, 2, 3, 7, 8, 9, 11, 12, and 13; Table 2) of 13 patients who developed HCC during entecavir treatment (Fig. 4).